<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78589</article-id><article-id pub-id-type="doi">10.7554/eLife.78589</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>A high-throughput yeast display approach to profile pathogen proteomes for MHC-II binding</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-274892"><name><surname>Huisman</surname><given-names>Brooke D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6229-6498</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-274893"><name><surname>Dai</surname><given-names>Zheng</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275160"><name><surname>Gifford</surname><given-names>David K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-182264"><name><surname>Birnbaum</surname><given-names>Michael E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2281-3518</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biological Engineering</institution>, <institution>Massachusetts Institute of Technology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Computer Science and Artificial Intelligence Laboratory</institution>, <institution>Massachusetts Institute of Technology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-4853"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Reviewing editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution>, <country>India</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>mbirnb@mit.edu</email> (MB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>04</day><month>07</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78589</elocation-id><history><date date-type="received"><day>12</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>04</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Huisman et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Huisman et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78589-v1.pdf"/><abstract><p>T cells play a critical role in the adaptive immune response, recognizing peptide antigens presented on the cell surface by Major Histocompatibility Complex (MHC) proteins. While assessing peptides for MHC binding is an important component of probing these interactions, traditional assays for testing peptides of interest for MHC binding are limited in throughput. Here we present a yeast display-based platform for assessing the binding of tens of thousands of user-defined peptides in a high throughput manner. We apply this approach to assess a tiled library covering the SARS-CoV-2 proteome and four dengue virus serotypes for binding to human class II MHCs, including HLA-DR401, -DR402, and -DR404. While the peptide datasets show broad agreement with previously described MHC-binding motifs, they additionally reveal experimentally validated computational false positives and false negatives. We therefore present this approach as able to complement current experimental datasets and computational predictions. Further, our yeast display approach underlines design considerations for epitope identification experiments and serves as a framework for examining relationships between viral conservation and MHC binding, which can be used to identify potentially high-interest peptide binders from viral proteins. These results demonstrate the utility of our approach to determine peptide-MHC binding interactions in a manner that can supplement and potentially enhance current algorithm-based approaches.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30-CA14051</award-id><principal-award-recipient><name><surname>Birnbaum</surname><given-names>Michael E</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000008</institution-id><institution>David and Lucile Packard Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Birnbaum</surname><given-names>Michael E</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Schmidt Futures</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gifford</surname><given-names>David K</given-names></name><name><surname>Birnbaum</surname><given-names>Michael E</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Huisman</surname><given-names>Brooke D</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U19-AI110495</award-id><principal-award-recipient><name><surname>Birnbaum</surname><given-names>Michael E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>David K Gifford, is a founder of ThinkTx..</p></fn><fn fn-type="conflict" id="conf3"><p>Michael E Birnbaum, is an equity holder in 3T Biosciences, and is a co-founder, equity holder, and consultant of Viralogic Therapeutics and Abata Therapeutics..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All deep sequencing data are deposited on the Sequence Read Archive (SRA), with accession codes PRJNA806475 [https://www.ncbi.nlm.nih.gov/bioproject/PRJNA806475] and PRJNA708266 [https://www.ncbi.nlm.nih.gov/bioproject/PRJNA708266]. Processed peptide data is provided as a supplemental dataset with this submission. Source data for FP measurements listed in Figure 4 is provided with this submission.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Huisman BD</collab><collab>Birnbaum ME</collab></person-group><year iso-8601-date="2022">2022</year><source>High-throughput yeast display approach to profiling pathogen proteomes for MHCII binding</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA806475">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA806475</ext-link><comment>SRA, PRJNA806475</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Huisman BD</collab><collab>Dai Z</collab><collab>Gifford DK</collab><collab>Birnbaum ME</collab></person-group><year iso-8601-date="2021">2021</year><source>Machine learning optimization of peptides for presentation by class II MHCs</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA708266">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA708266</ext-link><comment>SRA, PRJNA708266</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-78589-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>